Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Hanau, Germany
Countries of investment
  • USA
  • Canada
  • Germany
Investment stages
  • Seed
  • Series A
Industries
  • HealthCareSolutions
  • Additive Manufacturing
  • Advanced Food Ingredients
  • Cosmetics
  • Sustainability
About
Evonik is a global leader in specialty chemicals, dedicated to enhancing product performance through innovative solutions and integrated technology platforms across various industries.
Min check size
$500K
Max check size
$15M
Fund size
NPS

Investment Thesis

Evonik Venture Capital’s investment thesis centers on identifying and supporting startups with disruptive technologies and scalable business models that align with Evoniks core business areas. They seek companies that are working on advancements in chemistry, materials, and sustainable technologies.
Lead investor
Co Invest
Number of exits
Preferred contact method

Portfolio

Abolis

Allay Therapeutics

Biograil

Citrine Informatics

CircumFix Solutions

Decentral

Quick & Ethical Gender Determination

Non-animal Collagen

Laxxon

Modern Meadow

Peptide Production Tech

4D Human Skin Model

AI + IoT Farm Tech

Offshore Pipeline Materials

Graphene Battery Materials

Asia’s Leading Stereolithography 3D Printing

Velox

Bio-absorbable Vascular Implants.

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp